World Health Organization. Weekly epidemiological update on COVID-19-4 January 2023.2023. https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---4-january-2023. Accessed 12 Jan 2023.
Chinese Center for Disease Control and Prevention. A few things you need to know about the BQ.1. 2022. https://www.chinacdc.cn/yyrdgz/202212/t20221213_263008.html. Accessed 5 Jan 2023.
Ma XW. Report of the State Council on the promotion of Children′s health. 2022. http://www.npc.gov.cn/npc/c30834/202206/3442472183a94b29a3edd6a1cf978aa1.shtml. Accessed 6 Jan 2023.
National Health Commission of the People’s Republic of China. Diagnosis and treatment plan of SARS-CoV-2 Infection (Trial Version 10). 2023. http://www.nhc.gov.cn/ylyjs/pqt/202301/32de5b2ff9bf4eaa88e75bdf7223a65a/files/02ec13aadff048ffae227593a6363ee8.pdf. Accessed 6 Jan 2023.
Jiang RM, Xie ZD, Jiang Y, Lu XX, Jin RM, Zheng YJ, et al. Diagnosis, treatment and prevention of severe acute respiratory syndrome coronavirus 2 infection in children: experts’ consensus statement (fourth edition). Chin J Appl Clin Pediatr. 2022;37:1053–65 (In Chinese).
Desingu PA, Nagarajan K. Omicron BA.2 lineage spreads in clusters and is concentrated in Denmark. J Med Virol. 2022;94:2360–4.
Article CAS PubMed PubMed Central Google Scholar
World Health Organization. WHO Director-General′s opening remarks at the WHO press conference-13 April 2022. 2022. https://www.who.int/director-general/speeches/detail/3. Accessed 5 Jan 2023.
UK Health Security Agency. COVID-19 variants identified in the UK – latest updates. 2022. https://www.gov.uk/government/news/covid-19-variants-identified-in-the-uk-latest-updates. Accessed 5 Jan 2023.
Global Virus Network. COVID-19 variants and vaccines. 2021. https://gvn.org/covid-19-variants-and-vaccines. Accessed 5 Jan 2023.
Wang Q, Guo Y, Iketani S, Nair MS, Li Z, Mohri H, et al. Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5. Nature. 2022;608:603–8.
Article CAS PubMed PubMed Central Google Scholar
Aboubakr HA, Sharafeldin TA, Goyal SM. Stability of SARS-CoV-2 and other coronaviruses in the environment and on common touch surfaces and the influence of climatic conditions: a review. Transbound Emerg Dis. 2021;68:296–312.
Article CAS PubMed Google Scholar
Ren SY, Wang WB, Hao YG, Zhang HR, Wang ZC, Chen YL, et al. Stability and infectivity of coronaviruses in inanimate environments. World J Clin Cases. 2020;8:1391–9.
Article PubMed PubMed Central Google Scholar
van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med. 2020;382:1564–7.
Hirose R, Itoh Y, Ikegaya H, Miyazaki H, Watanabe N, Yoshida T, et al. Differences in environmental stability among SARS-CoV-2 variants of concern: both omicron BA.1 and BA.2 have higher stability. Clin Microbiol Infect. 2022;28:1486–91.
Article CAS PubMed PubMed Central Google Scholar
Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271-80.e8.
Article CAS PubMed PubMed Central Google Scholar
Sardu C, Gambardella J, Morelli MB, Wang X, Marfella R, Santulli G, et al. Hypertension, thrombosis, kidney failure, and diabetes: is COVID-19 an endothelial disease? A comprehensive evaluation of clinical and basic evidence. J Clin Med. 2020;9:1417.
Article CAS PubMed PubMed Central Google Scholar
Ren X, Wen W, Fan X, Hou W, Su B, Cai P, et al. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas. Cell. 2021;184:1895-913.e19.
Article CAS PubMed PubMed Central Google Scholar
Hu B, Chan JF, Liu H, Liu Y, Chai Y, Shi J, et al. Spike mutations contributing to the altered entry preference of SARS-CoV-2 omicron BA.1 and BA.2. Emerg Microbes Infect. 2022;11:2275–87.
Article PubMed PubMed Central Google Scholar
Meng B, Abdullahi A, Ferreira IATM, Goonawardane N, Saito A, Kimura I, et al. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity. Nature. 2022;603:706–14.
Article CAS PubMed PubMed Central Google Scholar
Machado-Curbelo C, Gutiérrez-Gil J, González-Quevedo A. A shift in SARS-CoV-2 Omicron variant’s entry pathway might explain different clinical outcomes. MEDICC Rev. 2022;24:68–71.
Li H, Liu L, Zhang D, Xu J, Dai H, Tang N, et al. SARS-CoV-2 and viral sepsis: observations and hypotheses. Lancet. 2020;395:1517–20.
Article CAS PubMed PubMed Central Google Scholar
Chi H, Chang L, Chao YC, Lin DS, Yang HW, Fang LC, et al. Pathogenesis and preventive tactics of immune-mediated non-pulmonary COVID-19 in children and beyond. Int J Mol Sci. 2022;23:14157.
Article CAS PubMed PubMed Central Google Scholar
American Academy of Pediatrics. What is the case definition of multisystem inflammatory syndrome in children (MIS-C)?.2022. https://www.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/clinical-guidance/multisystem-inflammatory-syndrome-in-children-mis-c-interim-guidance. Accessed 6 Jan 2023.
Zhang Q, Bastard P, Liu Z, Le Pen J, Moncada-Velez M, Chen J, et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 2020;370:eabd4570.
Article CAS PubMed PubMed Central Google Scholar
Bastard P, Gervais A, Le Voyer T, Rosain J, Philippot Q, Manry J, et al. Autoantibodies neutralizing type I IFNs are present in -4% of uninfected individuals over 70 years old and account for -20% of COVID-19 deaths. Sci Immunol. 2021;6:eabl4340.
Article PubMed PubMed Central Google Scholar
Deshmukh V, Motwani R, Kumar A, Kumari C, Raza K. Histopathological observations in COVID-19: a systematic review. J Clin Pathol. 2021;74:76–83.
Article CAS PubMed Google Scholar
Calabrese F, Pezzuto F, Fortarezza F, Hofman P, Kern I, Panizo A, et al. Pulmonary pathology and COVID-19: lessons from autopsy. The experience of European pulmonary pathologists. Virchows Arch. 2020;477:359–72.
Article CAS PubMed PubMed Central Google Scholar
Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324:782–93.
Article CAS PubMed Google Scholar
Menger J, Apostolidou S, Edler C, Kniep I, Kobbe R, Singer D, et al. Fatal outcome of SARS-CoV-2 infection (B1.1.7) in a 4-year-old child. Int J Legal Med. 2022;136:189–92.
Nomura E, Finn LS, Bauer A, Rozansky D, Iragorri S, Jenkins R, et al. Pathology findings in pediatric patients with COVID-19 and kidney dysfunction. Pediatr Nephrol. 2022;37:2375–81.
Article PubMed PubMed Central Google Scholar
Gomes I, Karmirian K, Oliveira JT, Pedrosa CDSG, Mendes MA, Rosman FC, et al. SARS-CoV-2 infection of the central nervous system in a 14-month-old child: a case report of a complete autopsy. Lancet Reg Health Am. 2021;2:100046.
PubMed PubMed Central Google Scholar
Duarte-Neto AN, Caldini EG, Gomes-Gouvêa MS, Kanamura CT, de Almeida Monteiro RA, Ferranti JF, et al. An autopsy study of the spectrum of severe COVID-19 in children: from SARS to different phenotypes of MIS-C. EClinicalMedicine. 2021;35:100850.
Article PubMed PubMed Central Google Scholar
Goussard P, Schubert P, Parker N, Myburgh C, Rabie H, van der Zalm MM, et al. Fatal SARS-CoV-2 Omicron variant in a young infant: autopsy findings. Pediatr Pulmonol. 2022;57:1363–5.
Article PubMed PubMed Central Google Scholar
Ji TY, Jiang YW. Pay attention to the nervous system involvement in SARS-CoV-2 infection in children. Chin J Pediatr. 2023;61:100–3 (In Chinese).
Expert Group on Intensive Care for SARS-CoV-2 Infection, Beijing Children′s Hospital, Capital Medical University, National Center for Children′s Health, Beijing Municipal Expert Group on Medical Treatment of SARS-CoV-2 Infection for Children. Recommendations for early identification, diagnosis and treatment of severe SARS-CoV-2 infection in children. Chin J Pediatr. 2023;61:199–202 (In Chinese).
Liguoro I, Pilotto C, Bonanni M, Ferrari ME, Pusiol A, Nocerino A, et al. SARS-COV-2 infection in children and newborns: a systematic review. Eur J Pediatr. 2020;179:1029–46.
Article CAS PubMed PubMed Central Google Scholar
Henderson LA, Canna SW, Friedman KG, Gorelik M, Lapidus SK, Bassiri H, et al. American college of rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 3. Arthritis Rheumatol. 2022;74:e1-20.
Article CAS PubMed PubMed Central Google Scholar
Scohy A, Anantharajah A, Bodéus M, Kabamba-Mukadi B, Verroken A, Rodriguez-Villalobos H, et al. Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis. J Clin Virol. 2020;129:104455.
Article CAS PubMed PubMed Central Google Scholar
Chinese Society of Radiology, Chinese Medical Association. Radiological diagnosis of COVID-19:expert recommendation from the Chinese society of radiology (First edition). Chin J Radiol. 2020;54:279–85 (In Chinese).
Ma HJ, Shao JB, Wang YJ, Zai AG, Zheng NN, Li Q, et al. High resolution CT features of COVID-19 in children. Chin J Radiol. 2020;54:310–3 (In Chinese).
Ma H, Hu J, Tian J, Zhou X, Li H, Laws MT, et al. A single-center, retrospective study of COVID-19 features in children: a descriptive investigation. BMC Med. 2020;18:123.
Article PubMed PubMed Central Google Scholar
Peng X, Guo Y, Xiao H, Xia W, Zhai A, Zhu B, et al. Overview of chest involvement at computed tomography in children with coronavirus disease 2019 (COVID-19). Pediatr
留言 (0)